A new cancer drug could stop cells from developing resistance to treatments.
FOX's Alex Hein reports in "Housecall for Health":
This is Housecall for Health.
In the war against cancer, scientists are in search of a new tactic to develop anti-evolution drugs that stop tumor cells from developing resistance to treatment. At Britain's Institute of Cancer Research, researchers are aiming to discover at least one new drug targeting a novel evolutionary mechanism and a new immunotherapy over the next five years.
While doctors have long-known about cancer's drug resistance, it is only now with advances in genetics and the development of ultra-fast DNA sequencing that scientists are unraveling the factors driving the process.
They're working on a controller of the stress response known as HSF-1, which may lead to a number of combination treatments to stop cancer evolving, similar to the drug cocktails used to control HIV or tuberculosis.
Another large part of the research will be driven by the use of mathematical models to predict the path of cancer evolution from tumor samples.
For more on this story, check FOXNewsHealth.com.
Housecall for Health, I'm Alex Hein, FOX News.